NEW YORK (Reuters Health) – When target cholesterol levels are not achieved with statin monotherapy in patients with mixed dyslipidemia, adding fenofibrate can tip the scales favorably. Dr.…
NEW YORK (Reuters Health) – For children with type 1 diabetes being treated with an insulin pump, lowering the basal insulin rate after exercise reduces the occurrence of…
NEW YORK (Reuters Health) – For children and very lean adults who use a 5 mm insulin needle, angling the injection into a pinched skin fold reduces pain…
NEW YORK (Reuters Health) – Patients with type 2 diabetes who have fairly high cholesterol levels despite simvastatin treatment do better with the addition of ezetimibe, Italian investigators…
NEW YORK (Reuters Health) – Independent of the usual markers of glycemic control, the amplitude of daily glucose excursions is associated with cognitive function in elderly patients with…
NEW YORK (Reuters Health) – Among patients with metabolic syndrome and mixed dyslipidemia, treatment with fenofibric acid in combination with a statin reduces the prevalence of metabolic syndrome…
NEW YORK (Reuters Health) – Elderly men with limitations in mobility who are treated with testosterone to improve strength appear to be at increased risk of cardiovascular-related adverse…
NEW YORK (Reuters Health) – For patients with diabetes and hypertension, an antihypertensive regimen combining an ACE inhibitor with a calcium channel blocker provides better protection against cardiovascular…
NEW YORK (Reuters Health) – Balloon angioplasty, drug-eluting stents, and bare metal stents appear to be equally effective at reducing death or myocardial infarction (MI) over a year’s…
NEW YORK (Reuters Health) – Oral antiglycemic agents have a modest effect on reducing glycated hemoglobin levels in patients with diabetes, suggests a new systematic review published online…